/PRNewswire/ The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new real-world evidence data showing the initiation of ERLEADA®.
/PRNewswire/ The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new real-world evidence data showing the initiation of ERLEADA®.
The cancer organization today largely reinstated its former advice that men with low-risk prostate cancer be offered active surveillance as the lone preferred initial treatment option.